Korkmaz H Ibrahim, Visscher Dafydd O, Helder Marco N, van Zuijlen Paul P M
Amsterdam UMC, locatie VUmc, afd. Plastische, Reconstructieve en Handchirurgie, Amsterdam.
Contact: H. Ibrahim Korkmaz (
Ned Tijdschr Geneeskd. 2021 May 12;165:D5676.
Five years ago in this journal we described our research into 3D bioprinting of ear cartilage for the purpose of making personalized cartilage implants for facial reconstruction. 3D bioprinting makes it possible to place living cells in a biodegradable scaffold to give a 3D structure to the tissue. We are able to develop a hybrid auricular cartilage implant model. However, Long term in vivo experiments are needed to test preclinical applicability. Nevertheless, the work presented in our studies provides a potential strategy for the use of biofabricated tissue constructs in the clinic. In short, 3D bioprinting is still in its infancy and has no direct clinical application yet. Before the step to the clinic can be made, the technique still has to go through a preclinical phase in which it is investigated how the 3D printed tissue would appear in vivo.
五年前,我们在这本期刊上描述了我们对耳软骨3D生物打印的研究,目的是制造用于面部重建的个性化软骨植入物。3D生物打印使将活细胞放置在可生物降解的支架中以赋予组织3D结构成为可能。我们能够开发出一种混合耳廓软骨植入模型。然而,需要进行长期的体内实验来测试临床前适用性。尽管如此,我们研究中展示的工作为生物制造的组织构建体在临床上的应用提供了一种潜在策略。简而言之,3D生物打印仍处于起步阶段,尚未有直接的临床应用。在迈向临床应用之前,该技术仍需经历一个临床前阶段,在此阶段要研究3D打印组织在体内的表现。